FinanceAsianet Newsable
Capricor stock plunges after FDA panel vote
in5points
Capricor stock is headed for its worst week on record after a negative FDA advisory committee vote.
One analyst sees the stock dropping to $2, while retail investors hold out hope.
The negative FDA advisory committee vote rattled Wall Street.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically